Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 10-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,241 | 555 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 7,855 |
| TOTAL | $7,894 | $588 | $N/A | $N/A | $7,855 |
| Non-Current Assets | |||||
| PPE Net | 18 | N/A | N/A | N/A | 41,359 |
| Other Non-Current Assets | 0 | 95 | 0 | 0 | 4,422 |
| TOTAL | $18 | $95 | $N/A | $N/A | $45,781 |
| Total Assets | $7,912 | $683 | $N/A | $N/A | $53,636 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 282 | N/A | N/A | 3,850 |
| Accounts payable and accrued liabilities | 290 | 129 | 0 | 0 | 19,993 |
| Accrued Expenses | 22 | 24 | N/A | N/A | 11,382 |
| Other current liabilities | N/A | 763 | N/A | N/A | 0 |
| TOTAL | $311 | $1,233 | $N/A | $N/A | $69,615 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 448 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2,237 |
| Total Liabilities | $311 | $1,233 | $N/A | $N/A | $71,852 |
| Shareholders' Equity | |||||
| Common Shares | 17 | 13 | N/A | N/A | 55 |
| Retained earnings | -11,489 | -7,611 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -6,128 |
| TOTAL | $7,601 | $-549 | $N/A | $N/A | $7,690 |
| Total Liabilities And Equity | $7,912 | $683 | $0 | $0 | $79,542 |